Your session is about to expire
← Back to Search
Ketone Supplement
Beta-hydroxybutyric acid for Blood Sugar
N/A
Recruiting
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
over the age of 18;
able to fast overnight
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
Awards & highlights
Study Summary
This trial is studying the effects of three different ketone supplements on blood ketones and blood sugar levels.
Eligible Conditions
- Blood Sugar
- Ketosis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Blood beta-hydroxybutyrate
Secondary outcome measures
Blood glucose
Blood pressure
Gastrointestinal discomfort
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Beta-hydroxybutyric acidExperimental Treatment1 Intervention
1 x 237 mL
Group II: 1,3-ButanediolExperimental Treatment1 Intervention
1 x 35 mL
Group III: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoesterActive Control1 Intervention
1 x 20 mL
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,537 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger